Stauber Introduces Amendment to Drastically Reduce Cost of Insulin

December 10, 2019
Press Release

WASHINGTON, D.C. – Today, Congressman Pete Stauber (MN-08) introduced an amendment to dramatically lower the cost of insulin at the pharmacy counter. Stauber introduced his amendment to the House Rules Committee to modify H.R. 3, the Lower Drug Costs Now Act.

Of his amendment, Stauber stated, “Too often, I hear from Minnesotans who are struggling to cover the rising cost of insulin, which can be hundreds or even thousands of dollars a month. These high costs often force families and seniors to make the difficult choice between buying this critical medication or putting food on the table. As more and more individuals across the nation die from rationing insulin, I believe Members of Congress have a moral responsibility to act. My amendment will directly reduce the cost of this lifesaving drug and I strongly urge my colleagues to support it.”

Currently, insulin is one of the most rebated drugs on the market. Stauber’s amendment would require rebates to go directly to the consumers rather than the middlemen, reducing the cost of insulin by up to 75 percent.

It would also mandate a report to Congress on how this amendment impacts the cost of insulin and saves consumers money.